| Dr Michael Cody Scarbrough, MD | |
|
3037 Corder Dr, Corinth, MS 38834-6216 | |
| (662) 284-8565 | |
| Not Available |
| Full Name | Dr Michael Cody Scarbrough |
|---|---|
| Gender | Male |
| Speciality | Interventional Pain Management |
| Experience | 10 Years |
| Location | 3037 Corder Dr, Corinth, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114345949 | NPI | - | NPPES |
| 28159 | Other | MS | STATE MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 28159 (Mississippi) | Primary |
| 207LP2900X | Anesthesiology - Pain Medicine | 59501 (Tennessee) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Magnolia Regional Health Center | Corinth, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midsouth Spine And Pain Associates Pllc | 8729236625 | 6 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
A Johns Hopkins Medicine study finds that a single dose of the oral antibiotic azithromycin taken after trichiasis eye surgery can reduce the frequency with which eyelashes turn back in and abrade the eye.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced that it has entered into a non-exclusive product distribution agreement with Siemens Healthcare for the sale of its Calypso® System in Europe. Under terms of the agreement, Siemens retains non-exclusive rights to sell Calypso's real-time tracking technology to existing and prospective Siemens linear accelerator customers throughout Europe for a period of three years.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
› Verified 1 days ago
| Entity Name | Midsouth Spine And Pain Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477808657 PECOS PAC ID: 8729236625 Enrollment ID: O20121029000567 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
A Johns Hopkins Medicine study finds that a single dose of the oral antibiotic azithromycin taken after trichiasis eye surgery can reduce the frequency with which eyelashes turn back in and abrade the eye.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced that it has entered into a non-exclusive product distribution agreement with Siemens Healthcare for the sale of its Calypso® System in Europe. Under terms of the agreement, Siemens retains non-exclusive rights to sell Calypso's real-time tracking technology to existing and prospective Siemens linear accelerator customers throughout Europe for a period of three years.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
› Verified 1 days ago
| Entity Name | Pain Clinic Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306496567 PECOS PAC ID: 4486610664 Enrollment ID: O20191204002513 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
A Johns Hopkins Medicine study finds that a single dose of the oral antibiotic azithromycin taken after trichiasis eye surgery can reduce the frequency with which eyelashes turn back in and abrade the eye.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced that it has entered into a non-exclusive product distribution agreement with Siemens Healthcare for the sale of its Calypso® System in Europe. Under terms of the agreement, Siemens retains non-exclusive rights to sell Calypso's real-time tracking technology to existing and prospective Siemens linear accelerator customers throughout Europe for a period of three years.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael Cody Scarbrough, MD Po Box 1740, Corinth, MS 38835-1740 Ph: (662) 284-8565 | Dr Michael Cody Scarbrough, MD 3037 Corder Dr, Corinth, MS 38834-6216 Ph: (662) 284-8565 |
News Archive
Soligenix, Inc., a late-stage biopharmaceutical company, reported today that it has completed enrollment of its Phase 1B clinical trial of RiVax™, a ricin subunit vaccine, in healthy volunteers. Preliminary results indicate that RiVax™ appears safe at all doses tested in volunteers. This trial is designed to assess the duration of immune responses using an adjuvant formulation of RiVax™ over a period of more than one year after vaccination.
A Johns Hopkins Medicine study finds that a single dose of the oral antibiotic azithromycin taken after trichiasis eye surgery can reduce the frequency with which eyelashes turn back in and abrade the eye.
Calypso Medical Technologies, Inc., a developer of real-time localization technology used for the precise tracking of tumor targets, today announced that it has entered into a non-exclusive product distribution agreement with Siemens Healthcare for the sale of its Calypso® System in Europe. Under terms of the agreement, Siemens retains non-exclusive rights to sell Calypso's real-time tracking technology to existing and prospective Siemens linear accelerator customers throughout Europe for a period of three years.
A new study published in the Journal for Healthcare Quality revealed that nursing resources vary significantly across different types of hospitals that care for children, and this has significant implications for quality and safety in pediatric medical care.
› Verified 1 days ago
Tina Marie Jobe, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 Alcorn Dr Ste 1e, Corinth, MS 38834 Phone: 662-665-0457 Fax: 662-665-0458 | |
Angel Rodriguez, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 Alcorn Dr, Ste 1a, Corinth, MS 38834 Phone: 662-665-0605 | |
Dr. Anthony Lane Armstrong, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 401 Alcorn Dr, Suite 1e, Corinth, MS 38834 Phone: 662-665-0457 Fax: 662-665-0458 |